|
PRPF38A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56521999999937E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.54519999999914E-05 |
| Normal-vs-Stage2 |
1.960520E-03 |
| Normal-vs-Stage3 |
9.739800E-03 |
| Normal-vs-Stage4 |
4.390000E-01 |
| Stage1-vs-Stage2 |
6.799800E-01 |
| Stage1-vs-Stage3 |
8.806800E-01 |
| Stage1-vs-Stage4 |
4.247400E-01 |
| Stage2-vs-Stage3 |
5.887800E-01 |
| Stage2-vs-Stage4 |
2.737400E-01 |
| Stage3-vs-Stage4 |
4.870200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58940000000363E-05 |
| Normal-vs-AfricanAmerican |
3.967900E-04 |
| Normal-vs-Asian |
7.807500E-04 |
| Caucasian-vs-AfricanAmerican |
9.165600E-01 |
| Caucasian-vs-Asian |
4.473600E-01 |
| AfricanAmerican-vs-Asian |
3.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33409999994549E-07 |
| Normal-vs-Female |
1.582160E-01 |
| Male-vs-Female |
4.014300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.751870E-02 |
| Normal-vs-Extreme_Weight |
2.381500E-04 |
| Normal-vs-Obese |
5.047000E-04 |
| Normal-vs-Extreme_Obese |
2.157900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.701800E-01 |
| Normal_Weight-vs-Obese |
9.432600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.817600E-01 |
| Extreme_Weight-vs-Obese |
6.424800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.337600E-01 |
| Obese-vs-Extreme_Obese |
4.820800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.479700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.219700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.41889999977418E-07 |
| Normal-vs-Age(81-100Yrs) |
1.039100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.656200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.599200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.516000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.051600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.886360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.144200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.004090E-04 |
| Normal-VS-Type2 PRCC |
4.32100000002933E-07 |
| Normal-VS-KIRP CIMP |
5.022300E-02 |
| Normal-VS-Unclassified PRCC |
3.022800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.987900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.862800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.902200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.345000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.485000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.134800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.98109999808239E-08 |
| Normal-vs-N1 |
6.098600E-01 |
| Normal-vs-N2 |
7.537000E-01 |
| N0-vs-N1 |
2.365700E-02 |
| N0-vs-N2 |
9.900500E-02 |
| N1-vs-N2 |
9.469600E-01 |
|
|
